 Everybody doing today, this is your host Rich from RichTVLive and I have more breaking news for you today and we love to bring you the news and we love to bring it to you first. So let's get right into the news, right? Like this, it's the big breaking news. Here we go, here we go. All right, so I brought you guys cardiotherapeutics first and they've been a big winner for the community. They started small and slow and went up big after my initial videos and interviews with the CEO and they've kind of come back down a little bit and now they've just listed on the NASDAQ under the symbol CRDL, which is currently the Canadian symbol, they are now going to list under that same symbol in America under CRDL, cardiotherapeutics to commence trading on the NASDAQ under the symbol CRDL. This is the big news breaking today and cardiotherapeutics is up. A clinical stage pathology company focused on developing initiative, innovative anti-inflammatory therapies for the treatment of cardiovascular disease announced today that is received final approval from the NASDAQ, that's it, that's what you need. NASDAQ Capital Markets LLC to list its common shares on the NASDAQ. The company shares will begin trading on August 10th, tomorrow, 2021 under the symbol CRDL. Companies common shares will continue to trade on the Toronto Stock Exchange TSX under the same symbol CRDL, its current symbol, concurrent with the listing of Cardiol's common shares on the NASDAQ, the shares will cease to be quoted on the OTCQX. David Ellsley, who I've interviewed, president and CEO of Cardiol Therapeutics said, listing on the NASDAQ is a major milestone for our company as NASDAQ is the premier global stock exchange for life science and biotechnology companies. As we continue to advance the research and clinical development of novel therapeutic strategies for inflammatory heart disease, we believe the NASDAQ listing will enable the execution of a more effective investor relations program aimed at increasing awareness of the Cardiol's story amongst investors and analysts in the US and ultimately lead to increased shareholder value about Cardiol Therapeutics. Cardiol Therapeutics is a clinical stage biotechnology company focused on the research and clinical development of innovative anti-inflammatory therapies for the treatment of cardiovascular disease, CVD. The company's lead product, Cardiol RX, which is trademarked, is a pharmaceutical-produced oral cannabinoidial formulation that is being investigated in a phase two, phase three outcome study in hospitalized patients testing positive for COVID-19 virus. This potential, this potentially registrational trial is designed to evaluate the efficacy and safety of Cardiol RX as a cardioprotective therapy to reduce mortality and major cardiovascular events in COVID-19 patients who have a prior history of or risk factors for CVD and to investigate the influence Cardiol RX has on key markets of inflammatory heart disease. Cardiol has filed an investigational new drug, IND application for phase two international trial that will investigate the anti-inflammatory and anti-fibrotic properties of Cardiol RX in patients with acute myocarditis, which remains the most common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of Cardiol RX and other anti-inflammatory therapies for the treatment of chronic heart failure, a leading cause of death and hospitalization in North America with associated annual healthcare costs in the U.S. alone exceeding 30 billion. So that's the big news. Cardiol will be trading on the NASDAQ under the simple CRDL tomorrow. Manana, this is the big breaking news. Now let me just show you guys something here. I wanna show you guys the chart, which we've been bringing to you guys for quite some time. Let's pull up the charts. All right, so we're gonna pull up the chart right now and let's take a look at this real quick. So this is the chart of Cardiol Therapeutics and you can see that we brought you guys this pick well in advance. In fact, let's break this down. So we brought this pick at about, say like about $1.87 near the bottom here. You can see it went as high as $5. So huge winner once again for a community. You can see we brought it around here, $1.87 and then it went as high as, let's say $5.35 is where it's been as high as, but you can see that it made a nice move up from the $1.87 mark when I was bringing it to last year to a high of $5.30 and then it has recently come back, right? So it kind of went up to these levels, went up to these levels and then you saw it come back down and retrace. So typically when you see something go up like this and then retrace, you could be potentially setting yourself for a nice dip by opportunity. You can see it's currently up 3% today on the news, CRDL in Canada, and you can see the US side CRTPF up 6% on this news equally in the United States. You can see it's gone from 182 to 419 and come all the way back down and it's starting to do a trend reversal where it seems like it's finding a bottom and it could be making a nice move back up. And that's what we love to do here. We love to break down these stocks to try to help you guys learn how to trade and learn how to win. Really, that's why we trade, right? We trade to win and what we do best here at Rich TV Live is break down stocks, break down the chart analysis, break down the news, identify bottoms, identify momentum and try to give you great opportunities to win in the markets. So we brought it to you first. It made a huge move up. It's come all the way back down, give them back those gains and now it's starting to do a trend reversal back up. So this might be a good opportunity to start positioning yourself in this play considering they're just now going to be listed on the NASDAQ tomorrow. They will no longer be CRTPF tomorrow. They will be as of tomorrow, the same symbol in Canada, CRDL. So currently CRDL in Canada and will be CRDL in America tomorrow. Love to know what you think about this video. Remember, Rich TV Live is strictly for information education purposes. Please do your due diligence, do your research before you invest in anything that we talk about here in Rich TV Live, invest in the best, the best is blessed and I think this company has a chance to be really, really special and they're making a big difference for people that have heart disease. This is their website. Let me show you guys their website. So this is the website and feel free to go to the website. It is right here. CardiolRx.com. Go to their website and learn about Cardiol Therapeutics which is dedicated to occurring heart failure. You can see here on their website, it says a clinical stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease and yet another company that we brought you first that is now listing on the NASDAQ. This has become a trend. We're starting to see this over and over again, companies that we brought you first that are being listed on the NASDAQ and typically when they get listed on the NASDAQ, not only does that prove that they were a success but it also proves that this may continue further because that means more institutional investment coming in to this deal. Love to know what you guys think about this video. If you liked the video, please smash the like button, comment down below, share the video everywhere and subscribe. If you're alive, thank you guys for some of your comments. Thank you Amanda. Amanda says, wow, so many of your rocket uplifting this summer, what a ride. And I believe this is just the beginning. We are, in my opinion, the number one platform in the world at identifying undervalued, underappreciated, underexposed opportunities before they explode. In doing that and in saying that, I believe we're also getting really good at identifying large cap stocks that have great dividends that are on dips or have momentum. If you'd like to learn how to trade, you can join our club at richpicksdaily.com where YouTube can learn how to trade absolutely free or become a VIP member and get amazing perks and access to 75 hours of training and videos, breaking down picks, breaking down deals and giving you an opportunity to learn how to win it every single day. We do it better than anybody else on the planet and the results speak for themselves. Amanda says, nice looking chart pre NASDAQ, I agree. I think it's getting ready to do something big and thank you, Jeffrey, for adding them to your watch list and thank you for your feedback. All right, guys, love to know what you guys think about this video. Big green day for us here at Rich TV Live. We've been communicating about so many different picks that are up and in the green today. If you're not winning, you're probably not watching. We bring you the winners and we bring them to you first. And this is no different, just another pick that we brought to you guys first. Thank you guys for watching. Put CRDL on your watch list, put on your radar. They will be on the NASDAQ tomorrow. They are also on the Toronto Stock Exchange under the symbol CRDL and we brought it to you first. Just another rocket to put in your pocket that we brought to you first that will be on the NASDAQ tomorrow. This is a trend. The trend is your friend. This is your boy Rich from Rich TV Live. If you're not winning, you're not watching. Thank you for watching everybody. Your boy's out. Peace. If you liked the video, smash the like button, comment down below, share the video everywhere and subscribe. If you're live, you're boy Rich from Rich TV Live. No need to panic. Never fear, your boy Rich is here from Rich TV Live. Come on. Peace.